4 unknown, 2 completed. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Unknown 4, Completed 2 |
Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City Histoplasma Urine Antigen Lateral Flow Antigen test, Cryptococcal Lateral Flow Antigen test, Tuberculosis-lipoarabinomannan Lateral Flow Antigen test - Acquired Immunodeficiency Syndrome, Histoplasmosis AIDS | Not applicable | Unknown | National Institute of Respiratory Diseases, Mexico | 211 | 2023-04-01 | 2023-01-17 |
| Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis Amphotericin B Colloidal Dispersion, flucytosine, fluconazole - Cryptococcal Meningitis | Not applicable | Unknown | Peking Union Medical College Hospital | 30 | 2022-08-22 | 2022-07-22 |
| Driving Reduced AIDS-associated Meningo-encephalitis Mortality DREAMM - AIDS-Related Opportunistic Infections, Meningo-encephalitis | Not applicable | Completed | St George's, University of London | 495 | 2016-04-23 | 2022-05-04 |
| Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS Fluconazole, Antiretroviral therapy - Cryptococcal Meningitis | Not applicable | Unknown | ANRS, Emerging Infectious Diseases | 186 | 2015-07-01 | 2018-03-15 |
| Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis Liposomal amphotericin B, Amphotericin B-deoxycholate - Cryptococcal Meningitis | Not applicable | Unknown | TTY Biopharm | 84 | 2011-02-01 | 2014-05-12 |
| Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa Fluconazole, Fixed dose - Stavudine, lamivudine and Nevirapine, Fixed dose - Stavudine, Lamivudine, Nevirapine - Cryptococcal Meningitis, HIV Infections | Not applicable | Completed | University of Zimbabwe | 54 | 2006-10-01 | 2016-07-18 |
Meningitis, Cryptococcal (6) · AIDS-Related Opportunistic Infections (1) · Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Latent Tuberculosis (1) · Meningitis (1) · Meningitis, Bacterial (1) · Toxoplasmosis, Cerebral (1) · Tuberculosis, Meningeal (1)
Bacterial Infections and Mycoses (6) · Central Nervous System Diseases (6) · Central Nervous System Fungal Infections (6) · Central Nervous System Infections (6) · Cryptococcosis (6) · Infections (6) · Meningitis, Fungal (6) · Mycoses (6) · Nervous System Diseases (6) · Neuroinflammatory Diseases (6) · Meningitis (5) · Blood-Borne Infections (3) · Communicable Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3)
Fluconazole (3) · Amphotericin B (2) · Antiretroviral Therapy, Highly Active (1) · Flucytosine (1) · Injections (1) · Lamivudine (1) · Nevirapine (1) · Stavudine (1) · amphotericin B, deoxycholate drug combination (1) · liposomal amphotericin B (1)
ANRS, Emerging Infectious Diseases (1) · National Institute of Respiratory Diseases, Mexico (1) · Peking Union Medical College Hospital (1) · St George's, University of London (1) · TTY Biopharm (1) · University of Zimbabwe (1)
Cameroon (2) · China (1) · Malawi (1) · Mexico (1) · Taiwan (1) · Tanzania (1) · Zimbabwe (1)
Angela Loyse, MD (1) · Azure T Makadzange, MD, DPhil (1) · Charles Kouanfack, MD, PhD (1) · Chiratidzo E Ndhlovu, MBChB, FRCP (1) · Elvis Temfack, MD, MSc (1) · James Hakim, MBChB, FRCP (1) · Olivier Lortholary, MD, PhD (1) · Taisheng Li, PhD (1) · Thomas Harrison, MD (1) · Yee-chun Chen, MD (1)